Family Medicine · Dallas, TX
NPI
1598739658
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5709 W Lovers Ln
Dallas, TX, 75209
Phone (469) 913-8940
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
346 services
Medicare patients, 2024
93
Average age 72
Drug cost, 2024
$198K
3,807 prescriptions
Company payments, 2025
$758
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen K Baker was code 99213 (office e&m - established), 57 times for 48 patients. In total Karen K Baker billed 346 services in 28 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 57 | 48 | $50.33 | $2,869 |
| 99497 Care Management/Coordination | Office | 53 | 52 | $65.53 | $3,473 |
| 99214 Office E&M - Established | Office | 52 | 42 | $65.08 | $3,384 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 46 | 46 | $127.55 | $5,867 |
| G0008 Administration of influenza virus vaccine | Office | 28 | 26 | $32.05 | $897 |
| 90662 Vaccine Product | Office | 26 | 25 | $79.92 | $2,078 |
| G0009 Administration of pneumococcal vaccine | Office | 20 | 20 | $32.05 | $641 |
| 90732 Vaccine Product | Office | 11 | 11 | $130.80 | $1,439 |
By year: 2022 $23K for 372 services; 2023 $21K for 331 services; 2024 $25K for 346 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karen K Baker prescribed most often to Medicare patients was Atorvastatin Calcium, with 227 prescriptions and refills. In total Karen K Baker wrote 3,807 Medicare prescriptions that cost $198K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 227 | 652 | 74 | $1,939 |
| Amlodipine Besylate Generic | 181 | 514 | 54 | $927 |
| Losartan Potassium Generic | 148 | 393 | 42 | $1,243 |
| Lisinopril Generic | 147 | 393 | 42 | $944 |
| Levothyroxine Sodium Generic | 143 | 405 | 43 | $1,156 |
| Metformin Hcl Generic | 111 | 316 | 35 | $923 |
| Gabapentin Generic | 95 | 144 | 25 | $1,472 |
| Omeprazole Generic | 81 | 213 | 28 | $1,637 |
| Meloxicam Generic | 74 | 106 | 22 | $107 |
| Rosuvastatin Calcium Generic | 70 | 201 | 21 | $710 |
| Pravastatin Sodium Generic | 68 | 195 | 20 | $569 |
| Simvastatin Generic | 63 | 175 | 16 | $449 |
| Hydrochlorothiazide Generic | 58 | 167 | 17 | $237 |
| Montelukast Sodium Generic | 53 | 150 | 19 | $197 |
| Metoprolol Succinate Generic | 53 | 134 | 14 | $988 |
Brand drugs: 354 claims; generic drugs: 3,440 claims; opioid claims: 60.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karen K Baker $758 ($758 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $108.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $108 |
| Abbvie Inc. ABBV | 4 | $83.14 |
| Lilly USA, LLC LLY | 4 | $76.6 |
| Pfizer Inc. PFE | 4 | $70.39 |
| Amgen Inc. AMGN | 4 | $64.53 |
| Gilead Sciences, Inc. GILD | 3 | $61.38 |
| Novo Nordisk Inc NVO | 3 | $61.24 |
| Exact Sciences Corporation EXAS | 2 | $45.86 |
| ViiV Healthcare Company GSK | 2 | $41.85 |
| Sanofi Pasteur Inc. SNY | 1 | $35.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.